Page 148 - MEMORIA ANUAL 2020

GRUPO ESPAÑOL DE LEUCEMIA MIELOIDE CRÓNICA (GELMC)
MEMORIA ANUAL 2020 SOCIEDAD ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
FUNDACIÓN ESPAÑOLA
DE HEMATOLOGÍA Y HEMOTERAPIA
Presentaciones orales
Congresos internacionales
• 62nd ASH Annual Meeting and Exposition. December 5-8, 2020:
– Efficacy and Safety of Front-Line Nilotinib Treatment and Discontinuation in Older Patients (≥65 years) with Chronic Myeloid Leukemia in Chronic Phase Who Have Achieved MR4.5: Results from ENESTfreedom.
García Gutiérrez JV, Radich JP, Hochhaus A, Saglio G, Masszi T, Hellmann A, Stentoft J, Gómez Casares MT, Conneally E, le Coutre PD, Gattermann N, Martino B, Saussele S, Giles FJ, Aimone P, Li S, Titorenko K, Ross DM, FRACP, FRCPA.
– Safety and Efficacy Profile of Asciminib As Treatment in Chronic Myeloid Leukemia Patients after Several Tyrosine-Kinase Inhibitors Failure.
Luna A, Estrada N, Boque C, Xicoy B, Giraldo P, Angona A, Álvarez-Larrán A, Sánchez-Guijo F, Ramírez MJ, Alonso-Domínguez JM, Mora E, Vélez P, Rosell A, Colorado Araújo M, Cuevas B, Sagüés M, Cortes M, Pérez Encinas M, Casado Montero LF, Moreno Vega M, Serrano L, Gómez V, García-Hernández C, Lakhwani Lakhwani S, Paz Coll A, de Paz R, Suárez-Varela S, Fernández-Ruiz A, Pérez López R, Ortiz- Fernández A, Jiménez-Velasco A, García-Gutiérrez V.
– Long-Term Cardiac, Vascular, and Hypertension Safety of Bosutinib (BOS) Versus Imatinib (IMA) for Newly Diagnosed Chronic Myeloid Leukemia (CML): Results from the Bfore Trial.
Cortes JE, le Coutre PD, Gambacorti-Passerini C, Hjorth-Hansen H, Raanani P, García-Gutiérrez V, Kota V, Purcell S, Viqueira A, Leip E, Brümmendorf TH.
• 25th Congress of European Hematology Association. Virtual congress. June, 11-21 2020:
– Characterization of phenotypic and genotypic markers as predictors of relapse during treat- ment-free remission in patients with chronic myeloid leukemia.
EHA Library. 06/12/20; 294646; EP728.
Vigón L, Galán M, Luna A, Rodríguez-Mora S, Bautista G, Steegmann JL, Piris-Villaespesa M, López- Huertas MR, García-Gutiérrez V, Coiras M.
148